iCAD to Participate in Two Upcoming Investor Conferences

NASHUA, N.H., May 22, 2017 (GLOBE NEWSWIRE) — iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that management will be participating in the 14th Annual Craig-Hallum Institutional Investor Conference, as well as presenting at the 7th Annual LD Micro Invitational Conference.